Floatz logo

IMMUNOGLOBULIN G2, ANTI-(HUMAN CD19 (ANTIGEN)) (SYNTHETIC HUMAN MONOCLONAL MEDI-551 HEAVY CHAIN), DISULFIDE WITH SYNTHETIC HUMAN MONOCLONAL MEDI-551 .KAPPA.-CHAIN, DIMER

Relapsed/Refractory Aggressive B-cell Lymphomas

MedImmune LLCmonoclonal_antibodyPhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

28 Active assets in the Relapsed/Refractory Aggressive B-cell Lymphomas cohort.

Asset / SponsorPhaseRating
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Shanghai EpimAb Biotherapeutics Co., Ltd.
Phase 3BB
Eloxatin
Shanghai EpimAb Biotherapeutics Co., Ltd.
Phase 2BB
LIPEGFILGRASTIM
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 3BB
(+)-VINCRISTINE
Universität des Saarlandes
Phase 3B
PEGFILGRASTIM
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 3B

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G2, ANTI-(HUMAN CD19 (ANTIGEN)) (SYNTHETIC HUMAN MONOCLONAL MEDI-551 HEAVY CHAIN), DISULFIDE WITH SYNTHETIC HUMAN MONOCLONAL MEDI-551 .KAPPA.-CHAIN, DIMER is also rated in:

chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
B
Indicative ·
57 / 100
View asset →
diffuse large B-cell lymphomaDormant
CCC
Indicative ·
54 / 100
View asset →
autoimmune encephalitisDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →